project id: TCGA-SKCM; case submitter id: TCGA-BF-A5ER; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 9.4; age at index: 63; days to birth: -23199; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23199; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 327.0; icd 10 code: C44.5; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Skin of trunk; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 91; initial weight: 170.0; sample id: 38c53576-d7cf-4700-b205-13711812c1f0; sample submitter id: TCGA-BF-A5ER-01A; portion id: 615cac2d-f6b6-451f-9049-bf6ffb936b6c; portion submitter id: TCGA-BF-A5ER-01A-12; slide id: afaf029a-fb17-4ff5-9221-4570315d32c6; slide submitter id: TCGA-BF-A5ER-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 96.0; section location: TOP;